Showing results (2211-2220 of 4,124) with videos related to
Sort By:
Pageof 413
Human Gene Therapy|March 21, 2000
Chemoprotection of hematopoietic cells by a mutant P-glycoprotein resistant to a potent chemosensitizer of multidrug-resistant cancersP Hafkemeyer, T Licht, I Pastan, et al.Human Gene Therapy|March 21, 2000
Effect of changes in expression of the amphotropic retroviral receptor PiT-2 on transduction efficiency and viral titer: implications for gene therapyC Macdonald, S Walker, M Watts, et al.Human Gene Therapy|March 21, 2000
Liver bypass significantly increases the transduction efficiency of recombinant adenoviral vectors in the lung, intestine, and kidneyX Ye, M Jerebtsova, P E RayHuman Gene Therapy|October 6, 2000
Molecular adaptors for vascular-targeted adenoviral gene deliveryM Trepel, M Grifman, M D Weitzman, et al.Human Gene Therapy|December 19, 2000
Preservation of graft-versus-infection effects after suicide gene therapy for prevention of graft-versus-host diseaseJ L Cohen, M F Saron, O Boyer, et al.Human Gene Therapy|December 19, 2000
Differentiation and expansion of lentivirus vector-marked dendritic cells derived from human CD34(+) cellsJ T Evans, P Cravens, P E Lipsky, et al.Human Gene Therapy|January 6, 2023
Biodistribution of Adeno-Associated Virus Gene Therapy Following Cerebrospinal Fluid-Directed AdministrationXin Chen, Daniel A Lim, Michael W Lawlor, et al.Human Gene Therapy|February 18, 1999
Induction of apoptosis of cytokine-producing bladder cancer cells by adenovirus-mediated IkappaBalpha overexpressionM Sumitomo, M Tachibana, C Ozu, et al.Human Gene Therapy|February 18, 1999
Tumor gene therapy made easy: allogeneic major histocompatibility complex in the C6 rat glioma modelA S Beutler, M S Banck, D Wedekind, et al.Human Gene Therapy|February 18, 1999
Anti-tumor activity of human T cells expressing the CC49-zeta chimeric immune receptorR P McGuinness, Y Ge, S D Patel, et al.Pageof 413